Objective: To determine the accuracy of the patent ductus arteriosus:left pulmonary artery ratio (PDA:LPA) on echocardiogram (ECHO) at 3-day postnatal in predicting spontaneous PDA closure in neonates p30 weeks gestational age (GA).
Introduction
A significant left-to-right shunt across a patent ductus arteriosus (PDA) may lead to decreased systemic perfusion and pulmonary over-perfusion in preterm VLBW (very low birth weight; p1500 g) neonates. 1 These alterations have been implicated in the pathogenesis of co-morbidities, including CLD (chronic lung disease), 2 ICH (intracranial hemorrhage), 3 necrotizing enterocolitis (NEC) 4 and ROP (retinopathy of prematurity), 5 which has resulted in prophylactic PDA closure in some VLBW neonates. 6, 7 These relationships have recently been challenged [7] [8] [9] since early PDA closure failed to improve neurodevelopmental status, 10 incidence of NEC, intraventricular hemorrhage 11 or death. 10, 11 Notably, these co-morbidities correlated best with decreasing gestational age (GA); 12 for example, when GA is considered, presence of a PDA does not increase ROP incidence. 13 One explanation for failure of clinical trials of PDA closure to show improvement in outcomes may be related to high spontaneous closure rates, 14 which also correlate with increasing GA. 15, 16 In a study of 122 neonates <1000 g birth weight, overall spontaneous closure was 34%; when stratified by GA, it was B80% in neonates >29 weeks GA. 15 Review of echocardiograms (ECHOs) in that population revealed that the PDA:left pulmonary artery ratio (PDA:LPA) determined by an ECHO at <4 days of life was a sensitive predictor of subsequent need for closure of a symptomatic PDA (sPDA). 17 Neonates with moderate-to-large ductus (PDA:LPA X0.5 (ref. 18)) on initial ECHO had a 15-times greater likelihood of requiring treatment for an sPDA compared to those with a closedto-small ductus (PDA:LPA <0.5), regardless of GA. This, however, has not been studied prospectively in another population. Thus, our objective was to prospectively study echocardiographic parameters in neonates p30 weeks GA and determine if a closed-to-small PDA defined by PDA:LPA on an ECHO at 3 days postnatal is an early and accurate predictor of spontaneous PDA closure. The study was observational in regards to the clinical management of these neonates, which was driven by the primary care team based on standard of care. 19 furthermore, spontaneous closure occurs at a mean of 4.3±2 days. 15 A focused ECHO was performed at 10 days postnatal (9 to 11 days) to evaluate ductal patency. This age was chosen since spontaneous closure occurs by 7 to 10 days. 10, 15 Results of ECHOs were not available to the primary care team; however, if an ECHO was ordered within 24 h of a study, results were provided. An sPDA at our institution was defined as: 20 tachycardia at rest heart rate >165 b.p.m.), bounding pulses, wide pulse pressures (>20 mm Hg), systolic murmur consistent with a PDA, radiographic evidence of cardiomegaly or increased pulmonary vascular markings, increasing ventilator or oxygen requirements, and/or worsening metabolic acidosis. Treatment was pursued if in addition to clinical parameters, ECHO evaluation showed a ductal diameter >1.5 mm, retrograde diastolic flow in the descending aorta and a left atrium to aortic root ratio of >1.4. Prophylactic closure was not used. Medical treatment consisted of three doses of intravenous indomethacin (0.2 mg kg -1 every 12 h). Indomethacin was contraindicated in the presence of active bleeding, NEC, thrombocytopenia (<60 000 mm -3 ), urine output <1 ml kg -1 per hour and/or a serum creatinine >1.2 mg dl -1 . Surgical ligation was performed if indomethacin was contraindicated or after failed medical therapy defined as the recurrence of an sPDA following a completed course of indomethacin.
Methods

Subjects
Echocardiographic measurements ECHO data were collected using an Acuson Sequoia C512 system (Acuson, Mountain View, CA, USA) equipped with a 10-MHz color Doppler transducer with simultaneous ECG recording. ECHOs were performed by two of the authors (PT or CR) and independently reviewed by them without knowledge of clinical outcomes. Interrater variability was determined using the k-test. The PDA:LPA was measured in the suprasternal long-axis view. The PDA was measured at its smallest diameter; LPA diameter was measured at the bifurcation of the main pulmonary artery. A ratio <0.5 identified a closed-to-small PDA; X0.5 was considered moderateto-large. 18 Measurements were performed on two-dimensional (2D) images. We also examined previously described ECHO measurements to determine their contribution in the prediction of spontaneous PDA closure: 21 
Data analysis
Neonates were stratified into <27 weeks and 27 to 30 week GA; each group was dichotomized using the PDA:LPA. The gestational age categories were chosen to correlate with our retrospective study. 17 Spontaneous PDA closure was defined as a closed-to-small PDA on the second ECHO in the absence of any treatment during the hospitalization. Non-spontaneous closure, therefore, was defined as a moderate-to-large PDA on the second ECHO in the absence of any intervention, or those who required surgical or medical intervention for an sPDA at any time during the hospital stay. Statistical testing of dichotomous variables was performed using w 2 and Fisher's exact t-test. Specificity, sensitivity and PPV (positive predictive value) and NPV (negative predictive value) were calculated for all ECHO markers. Classification tree analysis, conditional inference tree analysis and multiple logistical regression were conducted to determine the best set of predictors for closure. Classification tree is a method for multivariate analysis that allows for study of simultaneous influence of a series of independent variables on the one dependent variable. Statistical analyses were done using SAS9.2 (SAS Institute, Cary, NC, USA) and R2.12 (Auckland, New Zealand).
Results
We consented 107 neonates, 90% of whom completed the protocol ( Figure 1 ). Three died before completing the study, one withdrew before the second ECHO, one was too unstable to undergo an Figure 1 The distribution of neonates p30 weeks gestational age delivered at Parkland Memorial Hospital during the study period.
Prediction of ductal closure in neonates PP Thankavel et al ECHO, two received medical treatment for an sPDA before the first ECHO and three had CHD (small muscular ventricular septal defect in two and tricuspid atresia in another). The first ECHO in one neonate was unavailable due to technical problems. Nineteen neonates refused consent. Their GA distribution resembled the study population (26% <27 week GA and 73% 27 to 30 weeks GA vs 32% and 67%, respectively; P ¼ 0.8). No differences were observed in the characteristics (birth weight, Apgar scores, need for mechanical ventilation, ethnicity and gender) of the study vs non-study patients. Eighty-one percent of the cohort were Hispanic, mirroring the delivery population (Table 1) . Spontaneous closure for the entire study group (n ¼ 96) was 63%. Twenty (65%) neonates <27weeks (Table 2a ) had a PDA:LPA <0.5 by initial ECHO and 11 (35%) a PDA:LPA X0.5; spontaneous closure at 10 days postnatal was 60% and 9%, respectively (P ¼ 0.01). Their overall spontaneous closure rate was 42%. The PPV (ability to predict spontaneous ductal closure by a PDA:LPA <0.5 on initial ECHO) was 60%. The NPV (ability to predict nonspontaneous ductal closure by a PDA:LPA X0.5 on initial ECHO) was 91%. The sensitivity and specificity were 92% and 55%, respectively.
In neonates 27 to 30 week GA (Table 2b ), the PDA:LPA was <0.5 in 43 (66%) and X0.5 in 22 (34%). Their spontaneous closure rates were 95% and 27%, respectively (P<0.0001); overall closure was 72%. The PPV was 95%, NPV 73%, sensitivity 87% and specificity 89%. We also examined PDA:LPA cutoff values from 0.4 to 0.6 in both groups; 0.5 had the best predictive value. In addition, the PDA:LPA ratio in classifying ductal size has previously been established in the literature. 18 Absolute PDA:LPA ratio in each gestations age group was also analyzed ( Figure 2 ). The inter-observer variability for the first ECHO assessed by k statistic was 0.84 (95% confidence interval: 0.722 to 0.953). There were no differences in the determination of the PDA:LPA classification on the second ECHO. Thirty-six (38%) neonates were categorized as non-spontaneous closure; 31 (32% of the 96 neonates studied) received indomethacin and three received a second course. The mean age at first dose was 8 days (range 4 to 26 days). A higher proportion of neonates in the younger GA group received indomethacin (48% at <27 weeks vs 25% at 27 to 30 weeks, P ¼ 0.02). Fourteen (15% of 96) neonates underwent surgical ligation (mean age 26 days; range 16 to 56 days); 11 (11% of 96) failed medical therapy and 3 (3% of 96) had primary surgical ligation. The mean age of medical therapy in neonates who failed was 8.8 days (range 4 to 18 days), similar to the overall medical treatment group. The proportion failing medical therapy was similar in both GA groups, 40% and 31% (P ¼ 0.6). In two neonates, the PDA was not hemodynamically significant at discharge; one subsequently underwent transcatheter device closure while the other had documented spontaneous closure.
The PDA reopened in six neonates (6%). Four had documented closure following indomethacin (mean age 6.7 days, median 6 days, range 4 to 10 days) and reopening that required surgical ligation at 16, 25, 45 and 56 days postnatal. Two had spontaneous closure (one by initial ECHO; the other by second ECHO) and subsequently developed a moderate size PDA; one underwent surgery and the second died before planned ligation. When standard ECHO PDA measurements were assessed (Table 3) , only the PDA:LPA predicted spontaneous closure in the overall cohort (P ¼ 0.0001). However, conditional inference tree analysis revealed that the LPA forward diastolic flow also predicted spontaneous ductal closure after adjusting for the PDA:LPA (P<0.001; Table 2 ). A new predictor was constructed based on PDA:LPA and LPA forward diastolic flow. This was available in 17 of 20 neonates <27 weeks GA with a PDA:LPA <0.5 on initial ECHO; this increased the specificity and slightly decreased the sensitivity. Thus, a PDA:LPA <0.5 and LPA diastolic flow >0.3 m s -1 predicted non-spontaneous closure. The specificity and sensitivity of the composite score in neonates 27 to 30 weeks GA was not altered (Table 4) .
We also examined several co-morbidities associated with preterm birth and frequently considered to be associated with sPDA in a secondary analysis using the 72-h ECHO measurement of the PDA:LPA ratio (Table 5 ). There was no relationship between PDA size determined by the ratio and the co-morbidities noted for either GA group (Table 5a and b). There was, however, a gestational age affect with a significant increase in all co-morbidities except NEC in neonates <27 week GA, Pp0.05 (Table 5c ).
Discussion
In this prospective study, the PDA:LPA determined by ECHO at 3 days postnatal is an accurate marker of spontaneous PDA closure in neonates p30 week GA, confirming and extending previous observations in a new cohort. 17 Stratifying by GA allowed optimization of the predictive value of the test. The previously reported correlation 24, 25 between spontaneous ductal closure and increasing GA 15 was also confirmed, that is, there was a 42% spontaneous closure rate in neonates <27 weeks GA vs 72% in neonates 27 to 30 weeks. Several ECHO parameters previously described for prediction of an sPDA 21 were also examined (Table 3) . Although ductal diameter, LA:Ao ratio and LPA diastolic flow velocity (Table 2b and c) were independent predictors of spontaneous closure, the PDA:LPA was the only significant predictor of spontaneous closure by multiple logistic regression analysis. The reported sensitivity and specificity of the LA:Ao ratio are inconsistent. Harling et al. 26 reported a sensitivity of 56% and specificity of 50% using a cutoff of X1.4 on an ECHO at 72 h postnatal. Iyer and Evans, 27 however, reported a sensitivity of 82% and specificity of 87% using the same cutoff. A disadvantage of the LA:Ao is it may not reflect left atrial enlargement that occurs in a lateral plane rather than an anterior-posterior one. In addition, the LA:Ao is a surrogate marker of the pulmonary:systemic flow ratio. It is not specific for a ductal level shunt and therefore, should not be used in the presence of additional left-to-right shunting. Although an important adjunct to PDA evaluation, it should not be the primary tool. 28 Measurement of ductal diameter at 24 and 72 h postnatal is correlated with development of significant left-to-right shunting. Harling et al. 26 measured the PDA using color flow mapping, which overestimates ductal diameter. 29 In their study, ductal diameter >2 mm kg -1 at 72 h was the most accurate marker for predicting an sPDA with a sensitivity of 89% and specificity of 70% in neonates <32 weeks GA. They, however, did not examine interobserver and intra-observer variation. Kluckow and Evans 23 also used color flow mapping to measure PDA diameter. They reported that a diameter >1.5 mm at 24 h postnatal predicted an sPDA with a sensitivity of 81% and specificity of 85%. We agree that color flow mapping is often indicative of the site of narrowest diameter, but measurements by 2D images are more precise and correlate with angiographically derived measurements. 30 In our study, PDA and LPA diameters were obtained from 2D images with a similar sensitivity and specificity in predicting an sPDA (72% and 88%, respectively). Although color diameter was an independent predictor of closure, further analysis indicated that the PDA:LPA measurement by 2D images is superior. Furthermore, utilization of a ratio eliminates the need to index ductal diameter to weight since LPA size is the index in each neonate. Our measurements demonstrated excellent inter-observer reproducibility, making it feasible for use by others.
An interesting finding was the use of the LPA forward diastolic flow as an adjunct to improving specificity and accuracy in neonates <27 week GA. These neonates have a lower spontaneous closure rate, and the specificity of the PDA:LPA was only 55%. This indicates a high rate of false positives, that is, a high proportion of neonates with PDA:LPA<0.5 experience a persistent PDA requiring closure. Notably, a diastolic forward flow p0.3 m s -1 plus a PDA:LPA <0.5 improved prediction of spontaneous closure, which would decrease the need for treatment. The sensitivity of the PDA:LPA alone is high in both GA groups, signifying a low percentage of false negatives. Thus, most neonates with moderate-to-large PDA by early ECHO are correctly predicted to have non-spontaneous closure and will require treatment for an sPDA. Moreover, the use of both parameters in neonates p30 week GA may help address recent comments by Benitz 31 and the design of future studies. Although our primary outcome was spontaneous ductal closure, we also examined the incidence of co-morbidities. The trends did not differ in neonates with closed-to-small or moderate-to-large PDAs. With the exception of NEC, the incidence of CLD, ROP and ICH was inversely related with GA, in agreement with the NICHD Neonatal Research Network. 12 Although our study was not powered to identify a significant association with co-morbidities, our observations add to the existing literature questioning these relationships.
A limitation of our study was the definition of non-spontaneous closure rate as a PDA that remained moderate-to-large at 10 days or required medical or surgical treatment before discharge. By this definition, therapeutic intervention may have excluded neonates whose PDA might have spontaneously closed in the absence of treatment. We believe the criteria used for treatment are conservative and within accepted practice guidelines, that is, a combination of clinical and ECHO guidelines to establish diagnosis and treatment of an sPDA. 15, 20 While our study does not analyze the natural history of ductal closure, it reflects the current conservative approach to an sPDA. [31] [32] [33] In view of current clinical standards, it would be impossible to devise a study without PDA treatment. These are inherent limitations with an observational study. It is also worth noting that our study population was predominantly Hispanic. It, therefore, is possible that the lack of racial/ethnic diversity may be another limitation, although of uncertain significance.
Conclusion
Recently, several investigators 7-9,31,32 have challenged current PDA treatment strategies in preterm neonates due to lack of a proven cause-and-effect relationship with co-morbidities. Additionally, consistent high spontaneous closure rates have been reported, implying that a subset of neonates is unnecessarily exposed to the risk profile of medical and/or surgical interventions. It has been suggested that the ideal clinical trial to resolve or confirm these doubts should focus on a subgroup of neonates in whom the non-spontaneous closure rate is considered to remain high. 8 Indeed, if neonates in the present study had been enrolled in a clinical trial, the spontaneous closure rate of 63% might have masked any differences in outcomes between a treatment vs no treatment arm. By using GA and the PDA:LPA ratio, a very high-risk population of extremely preterm neonates can be accurately identified at 72 h of life, if our data are applicable to a more racially diverse population. This should allow for randomization into an early treatment arm and an alternative treatment arm. Analysis of outcomes between these two groups should identify a difference in outcomes, if one does indeed exist.
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